Fenfluramine challenge test as a predictor of outcome in major depression.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Psychopharmacology bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7507256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline

  2004cited by this paper
• Enhanced Serotonergic Responsivity Following Electroconvulsive Therapy in Patients with Major Depression

  1992cited by this paper
• Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients.

  1992cited by this paper
• Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormality.

  1991cited by this paper
• Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change

  1991cited by this paper
• d‐Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen‐induced alteration

  1991cited by this paper
• Hormonal responses to fenfluramine in depressed and control subjects.

  1990cited by this paper
• Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

  1990cited by this paper
• Effects of age and gender on CNS serotonergic responsivity in normal adults.

  1990cited by this paper
• Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients.

  1989cited by this paper
• The Fenfluramine Challenge Test in the Affective Spectrum: A Possible Marker of Endogeneity and Severity

  1988cited by this paper
• Effects of electrode placement on the efficacy of titrated, low-dose ECT.

  1987cited by this paper
• Therapeutic effects of serotonin uptake inhibitors in depression.

  1986cited by this paper
• Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.

  1984cited by this paper
• Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.

  1984cited by this paper
• CSF monoamine metabolites in melancholia

  1984cited by this paper
• Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

  1984cited by this paper
• Altered platelet serotonin uptake kinetics in schizophrenia and depression.

  1982cited by this paper
• Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression

  1979cited by this paper
• Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.

  1978cited by this paper
• Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients.

  1976cited by this paper
• Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

  1973cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• A Meta-analysis of Different Acupuncture Modalities Combined With Antidepressants to Reduce Major Depressive Disorder

  2024cites this paper
• The Involvement of Prolactin in Stress-Related Disorders

  2023cites this paper
• Basal prolactin levels in rat plasma correlates with response to antidepressant treatment in animal model of depression.

  2017cites this paper
• Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review

  2016cites this paper
• Prolactin and Somatostatin Responses to Antidepressant Therapy

  2016cites this paper
• Involvement of prolactin and somatostatin in depression and the mechanism of action of antidepressant drugs

  2013cites this paper
• Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile

  2012cites this paper
• Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine.

  2012cites this paper
• Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.

  2008cites this paper
• Personality, Serotonin, and Noradrenaline.

  2004cites this paper
• Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.

  2004cites this paper
• Serum Cholesterol in Treatment-Resistant Depression

  2003cites this paper
• Serum cholesterol and serotonergic function in major depressive disorder.

  2003cites this paper
• Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.

  2003influential citation
• Depression and Parkinson's disease: a conceptual challenge

  2002cites this paper
• Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients

  2002cites this paper
• Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression.

  2002cites this paper
• Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression

  2002cites this paper
• Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease

  2002cites this paper
• Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.

  2002cites this paper
• Prolactin Response to dl-Fenfluramine Challenge before and after Treatment with Paroxetine

  2001cites this paper
• Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram.

  2001cites this paper
• Affect theory and the neurobiology of affective dysregulation.

  2000cites this paper
• [Electroconvulsive therapy and serotonergic system].

  2000cites this paper
• Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?

  1999cites this paper
• Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging.

  1999cites this paper
• Serotonin and the prediction of response time to fluoxetine in patients with mild depression.

  1999cites this paper
• Fenfluramine challenge test predicts outcome in pharmacological treatment of patients with functional gastrointestinal disorder.

  1999cites this paper
• The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers.

  1999cites this paper
• Increased serotonin receptor density and platelet GPIIb/IIIa activation among smokers.

  1999cites this paper
• Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.

  1998cites this paper
• Test–retest variability of serotonin 5‐HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain

  1998cites this paper
• No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine.

  1998cites this paper
• Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response.

  1998cites this paper
• 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.

  1997cites this paper
• Cognitive Behavior Therapy Manual for Treatment of Depressed Inpatients

  1996cites this paper
• The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function

  1995cites this paper
• Do the endocrine and subjective effects of d‐fenfluramine predict response to selective serotonin reuptake inhibitors?

  1995cites this paper
• Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies.

  1994cites this paper